Four of the six companies that were part of the inaugural cohort of the ZeroTo510 accelerator program have been chosen to go on to the second phase of the program.
They’re getting an additional round of funding totaling $100,000 each. And one company has been chosen for a full round of venture funding.
The four companies selected for additional funding are:
::BioNanovations, which has developed a device that uses bionanotechnology for rapid diagnosis of bacterial infection.
::EcoSurg, which has developed an environmentally friendly alternative to traditional foam patient positioners used in surgeries.
::Nanophthalmics, which has developed, through the use of nanotechnology, a surgical device to more effectively treat corneal abrasions.
::and Urova Medical, which has developed a minimally invasive treatment to address feminine stress urinary incontinence.
An additional company – Restore Medical Solutions, which has developed a modular surgical tray and method for the reprocessing of sterile surgical instruments – received a term sheet to advance to a Series A round of venture capital funding. It will be co-led by Innova Memphis and MB Venture Partners.